Characterization of inhibitor binding to human kinesin spindle protein by site-directed mutagenesis.

Arch Biochem Biophys

Dept. of Cancer Biology and Therapeutics, Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA.

Published: April 2009

A number of inhibitors of kinesin spindle protein (KSP) have been described, which are known from X-ray crystallography studies to bind to an induced fit pocket defined by the L5 loop. We describe the characterization of eight mutant forms of KSP in which six residues that line this pocket have been altered. Mutants were analyzed by measuring rates of enzyme catalysis, in the presence and absence of six KSP inhibitors of four diverse structural classes and of varied ATP-competition status. Our analysis was in agreement with the model of binding established by the structural studies and suggests that binding energy is well distributed across functional groups in these molecules. The majority of the mutants retained significant enzymatic activity while diminishing inhibitor binding, indicating potential for the development of drug resistance. These data provide detailed information on interactions between inhibitor and binding pocket at the functional group level and enable the development of novel KSP inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.abb.2009.01.015DOI Listing

Publication Analysis

Top Keywords

inhibitor binding
12
kinesin spindle
8
spindle protein
8
ksp inhibitors
8
binding
5
characterization inhibitor
4
binding human
4
human kinesin
4
protein site-directed
4
site-directed mutagenesis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!